Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up
Abstract Background Major bleeding and allogeneic transfusion leads to negative outcomes in patients receiving cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urine trypsin inhibitor, relieves systemic inflammation and improves coagulation profiles with however sparse evidence of i...
Main Authors: | Peng Zhang, Hong Lv, Xia Qi, Wenjing Xiao, Qinghua Xue, Lei Zhang, Lihuan Li, Jia Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13019-020-01144-9 |
Similar Items
-
Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
by: Yan Qiu, et al.
Published: (2015-01-01) -
Protective effect of dexmedetomidine combined with ulinastatin on cardiopulmonary function injury caused by cardiopulmonary bypass surgery
by: Zhu Zhu, et al.
Published: (2016-11-01) -
Effect of ulinastatin on the pathological links related to myocardial injury and ischemia reperfusion after cardiac surgery under cardiopulmonary bypass
by: Ke-Qi Xie, et al.
Published: (2018-09-01) -
Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded study
by: Jieun Song, et al.
Published: (2013-04-01) -
VALUE OF LOCAL ADMINISTRATION OF TRANEXAMIC ACID IN CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
by: S. I. Sergey, et al.
Published: (2018-01-01)